Efficacy, safety and pharmacokinetics of subcutaneous azacitidine in Chinese patients with higher risk myelodysplastic syndromes: Results from a multicenter, single ‐arm, open‐label phase 2 study

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Source: Asia-Pacific Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research